Market Performance: Mixed Results Amid Tech Earnings On Wednesday, October 30, 2024, the U.S. stock market exhibited mixed performance as investors digested a flurry of tech earnings reports and key economic data. The S&P...
Major Indexes Show Modest Gains Amid Mixed Corporate Results As the trading day came to a close on Wednesday, October 30, 2024, U.S. stock markets posted modest gains, driven by strong earnings reports from...
Market Overview: October 30, 2024 As of Wednesday, October 30, 2024, the stock market is showing mixed performance, with technology stocks leading the way. The Nasdaq Composite is outperforming other major indexes, having reached...
The stock market on Wednesday, October 30, 2024, is showing mixed performance as investors digest a flurry of earnings reports and economic data. The tech-heavy Nasdaq Composite is leading the charge, building on its...
The stock market is showing positive momentum on Wednesday, October 30, 2024, as investors digest a flurry of corporate earnings reports and anticipate key economic data releases. Major market indexes are trending upward, with...
Market Overview: October 29, 2024 As of Tuesday, October 29, 2024, the stock market is poised for a pivotal week, with major indexes showing modest gains in early trading. Investors are keenly focused on...
Major Indexes Close Higher Amid Geopolitical Relief On Monday, October 28, 2024, U.S. stock markets closed higher, kicking off a pivotal week packed with Big Tech earnings, inflation updates, and crucial economic data. The...
Market Overview: October 28, 2024 As of 4:08 a.m. EST on Monday, October 28, 2024, U.S. stock futures are signaling a positive start to the trading week. Futures on the Nasdaq 100 (NDX), S&P...
Market Performance: Mixed Results Across Major Indexes On Friday, October 25, 2024, the U.S. stock market closed with mixed results across major indexes. The tech-heavy Nasdaq Composite led the charge, climbing 1.3% to reach...
Pharmaceutical giants Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) and Eli Lilly (NYSE:LLY) said on Tuesday that they are putting an end to their drug development collaboration that was meant to work on new diabetes drug. The...